A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples